M&A Deal Summary |
|
---|---|
Date | 2005-05-04 |
Target | Renal Care Group |
Sector | Healthcare Services |
Buyer(s) | Fresenius Medical Care |
Deal Type | Add-on Acquisition |
Deal Value | 3.5B USD |
Advisor(s) | BofA Securities Morgan Stanley (Financial) Cravath, Swaine & Moore Alston & Bird (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1996 |
Sector | Healthcare Services |
Employees | 117,128 |
Revenue | 19.5B EUR (2023) |
Fresenius Medical Care a kidney dialysis company, provides renal dialysis products and services. Fresenius Medical Care was founded in 1996 and is based in Bad Homburg, Germany.
DEAL STATS | # |
---|---|
Overall | 3 of 16 |
Sector (Healthcare Services) | 1 of 9 |
Type (Add-on Acquisition) | 2 of 15 |
State (Tennessee) | 1 of 2 |
Country (United States) | 2 of 12 |
Year (2005) | 2 of 2 |
Size (of disclosed) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-04-21 |
Haemotec
Vaudreuil-Dorion, Quebec, Canada Haemotec, Inc. is a manufacturer of hemodialysis concentrates. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-11-29 |
Renal Solutions
Warrendale, Pennsylvania, United States Renal Solutions, Inc., a medical device and healthcare service company, is commercializing the Allient(R) Sorbent Hemodialysis System, a revolutionary technology/service solution for the chronic and acute dialysis market. The Allient System, brings SMARRT (Sorbent Management for Advanced Renal Replacement Therapy) therapy to the dialysis field, opening new treatment options to dialysis professionals and patients by virtue of its ability to provide short, standard or extended duration hemodialysis therapy using just 1 and 1/2 gallons of ordinary drinking water. |
Buy | $190M |